Neuromod™ is a medical device manufacturer specialising in the clinical research, technology development, regulatory approval and commercialisation of neuromodulation devices. The company is focused on the development of a bi-modal neuromodulation device for chronic tinnitus. Tinnitus is the perception of illusory sound in the absence of an external source and is most commonly described as 'ringing in the ears'. Clinically significant tinnitus requiring specialist care occurs in 2.5% of the population.
The company was founded in Dublin, Ireland in 2010. The team comprises dedicated biomedical engineers, clinical scientists, surgeons and audiologists who are experienced in the research and development of neuromodulation devices and tinnitus diagnosis and treatment.